Albany, NY -- (SBWIRE) -- 08/17/2018 -- Prostate biopsy is a procedure to collect sample tissue from prostate to identify cancer. Prostate biopsy is performed after digital rectal exam and blood test (screening tests). Prostate cancer is a common type of cancer in men. According to American Cancer Society estimates, around 164,690 new prostate cancer cases are likely to be registered and around 29,430 deaths in 2018. Moreover, around 1 in 9 men will be diagnosed with prostate cancer in his lifetime. Prostate cancer develops primarily in older men of the U.S. and Africa. Around 6 out of 10 cases diagnosed with prostate cancer are in men aged 65 or above. Prostate cancer is quite rare in men below the age of 40. Average age at the time of diagnosis is around 66.
Prostate biopsy involves usage of a needle to accumulate tissue sample from prostate gland. The procedure is performed by doctors specialized in the male sex organs and urinary system. After the analysis of digital rectal exam or prostate-specific antigen (PSA) blood test, an urologist recommends prostate biopsy to confirm cancer. Collected sample of tissue from prostate gland is examined by doctors under microscope to check for abnormalities in cells which are symptoms of prostate cancer.
Collection of tissue sample for prostate biopsy is performed through two different methods. The first method involves passing a needle through the rectum walls. This method is known as transrectal biopsy. The second method involves inserting a needle into the skin potion present between the scrotum and anus. This method is known as transperineal biopsy.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43484
Rise in incidence rate of prostate cancer, increase in geriatric male population globally, and availability of advanced diagnostic devices are the major factors driving the global Prostate Biopsy Devices Market. Moreover, advancement in molecular diagnosis for prostate cancer augments the global prostate biopsy devices market. However, high cost of biopsy procedures and shortage of skilled professionals are the major restraints of the market.
The global prostate biopsy devices market can be segmented based on prostate biopsy type, end-user, and region. In terms of prostate biopsy type, the global market can be bifurcated into prostate needle biopsy and prostate liquid biopsy. Based on end-user, the global prostate biopsy devices market can be divided into hospitals, ambulatory surgical centers, and others.
The global prostate biopsy devices market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global prostate biopsy devices market due to availability of advanced biopsy devices. Awareness among the people about the disease is a major factor propelling the market in this region. The prostate biopsy devices market in Asia Pacific is anticipated to expand at a rapid pace due to increase in prevalence of prostate cancer. Lack of awareness about the disease and unavailability of advanced biopsy procedures and treatment in underdeveloped countries such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to augment the prostate biopsy devices market in Middle East & Africa.
Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43484